GuardionHealthSciences (002).jpg
Guardion Health Sciences Announces Appointment of Former Neutrogena and Coca-Cola Executive Jan Hall as President and Chief Executive Officer
30. Mai 2023 08:00 ET | Guardion Health Sciences, Inc.
HOUSTON, May 30, 2023 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”), a clinical nutrition company that offers a portfolio of science-based,...
GuardionHealthSciences (002).jpg
Guardion Health Sciences Announces Financial Results for the Quarter Ended March 31, 2023
15. Mai 2023 08:15 ET | Guardion Health Sciences, Inc.
HOUSTON, May 15, 2023 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”), a clinical nutrition company that offers a portfolio of science-based,...
GuardionHealthSciences (002).jpg
Guardion Health Sciences Announces Financial Results for the Year Ended December 31, 2022
17. April 2023 08:15 ET | Guardion Health Sciences, Inc.
HOUSTON, April 17, 2023 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”), a clinical nutrition company that offers a portfolio of science-based,...
GuardionHealthSciences (002).jpg
Guardion Health Sciences Announces Pricing of Aggregate $4.75 Million Institutional Private Placement of Series C and Series D Redeemable Preferred Stock
29. November 2022 17:06 ET | Guardion Health Sciences, Inc.
HOUSTON, Nov. 29, 2022 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (Nasdaq: GHSI), a clinical nutrition company that offers a portfolio of science-based,...
GuardionHealthSciences (002).jpg
Guardion Health Sciences Announces Financial Results for the Three Months and Nine Months Ended September 30, 2022
14. November 2022 08:25 ET | Guardion Health Sciences, Inc.
Viactiv® Generated Net Revenues of Approximately $2.6 Million or 96% of Net Revenues for the Quarter Ended September 30, 2022 Company Announces Program to Evaluate Strategic Alternatives HOUSTON,...
GuardionHealthSciences (002).jpg
Guardion Health Sciences Announces Clinical Results Indicating that Viactiv® Omega Boost™ Gel Bites Increase Omega-3 Levels in Just 4 weeks
06. Oktober 2022 08:00 ET | Guardion Health Sciences, Inc.
New Viactiv Omega Boost™ Gel Bites Clinically Proven to Increase Omega-3 Levels by 51% in Just 4 Weeks First-Ever Clinically Proven Gel Bites, with a Tasty Fruit Flavor and No Fish Burps, are a...
GuardionHealthSciences (002).jpg
Guardion Health Sciences Announces Financial Results for the Quarter Ended June 30, 2022
11. August 2022 08:20 ET | Guardion Health Sciences, Inc.
HOUSTON, Aug. 11, 2022 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”), a clinical nutrition company that offers a portfolio of science-based,...
GuardionHealthSciences (002).jpg
ISS Recommends Guardion Stockholders Vote for the Increase in Shares for Equity Plan and for the Reverse Stock Split at Guardion’s Upcoming 2022 Annual Stockholders’ Meeting
09. Juni 2022 09:00 ET | Guardion Health Sciences, Inc.
HOUSTON, June 09, 2022 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (NASDAQ: GHSI) announced that independent proxy advisory firm ISS recommends that Guardion...
GuardionHealthSciences (002).jpg
Guardion Health Sciences Announces Agreement with OmegaQuant Laboratories
01. Juni 2022 08:38 ET | Guardion Health Sciences, Inc.
HOUSTON, June 01, 2022 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (Nasdaq: GHSI) announced an agreement with OmegaQuant Laboratories (“OmegaQuant”) to provide...
GuardionHealthSciences (002).jpg
Guardion Health Sciences Announces New Viactiv Omega Boost Gel Bites Now Available for Purchase on Amazon
26. Mai 2022 09:00 ET | Guardion Health Sciences, Inc.
Consumers May Now Purchase Viactiv Omega Boost 1,200 mg Omega-3 Gel Bites Directly from Amazon Viactiv Omega Boost Gel Bites Provide 10x More Omega-3 Than the Leading Fish Oil Gummy, Without...